Acceleron Pharma

Investors/Media

Press Releases

Date Title and Summary View
Toggle Summary Acceleron Pharma to Present ACE-011 Bone Growth Data at the ASBMR 29th Annual Meeting
Acceleron Pharma to Present ACE-011 Bone Growth Data at the ASBMR 29th Annual Meeting CAMBRIDGE, MA – August 6, 2007 – Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, today announced it will present the
View HTML
Toggle Summary Pharmaceutical Executive: Acceleron Pharma’s Pipeline Selected to Top 7 Most Exciting Future Therapies and Technologies
Pharmaceutical Executive: Acceleron Pharma’s Pipeline Selected to Top 7 Most Exciting Future Therapies and Technologies Pharmaceutical Executive, August 1, 2007
View HTML
Toggle Summary Acceleron Pharma to Present at the 27th Annual Canaccord Adams Global Growth Conference
Acceleron Pharma to Present at the 27th Annual Canaccord Adams Global Growth Conference CAMBRIDGE, MA – July 31, 2007 - Acceleron Pharma, Inc., a biopharmaceutical company developing novel biotherapeutics, today announced that company President and Founder, John Knopf, Ph.D., will provide a
View HTML
Toggle Summary Boston Globe: Super-buff cattle may hold key to treating muscular diseases
Boston Globe: Super-buff cattle may hold key to treating muscular diseases Link to article
View HTML
Toggle Summary ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
Novel Approach Represents a Significant Advance for the Treatment of Cancer-related Bone Loss
View HTML
Toggle Summary Start-Up: Acceleron Pharma, Inc.-Releasing the Brakes on Bone and Muscle Growth
Start-Up: Acceleron Pharma, Inc.-Releasing the Brakes on Bone and Muscle Growth Start-Up: June 1, 2007
View HTML
Toggle Summary Acceleron Pharma’s ACE-031 Increases Muscle Mass and Strength in Preclinical Studies
Novel Compound Shown to be Promising Potential Therapy for Multiple Diseases with Unmet Medical Need
View HTML
Toggle Summary Acceleron Pharma Appoints James Desiderio, Ph.D. as Vice President, Program Managemen
Dr. Desiderio’s Expertise in Managing Development Programs in Companies with Multiple Products is Valuable as Acceleron’s Pipeline Rapidly Expands and Advances
View HTML
Toggle Summary GEN: Acceleron Takes on Bone & Muscle Repair
Genetic Engineering & Biotechnology News April 1, 2007 (Vol. 27, No. 7)
View HTML
Toggle Summary Acceleron Pharma Appoints Robert Steininger as Senior Vice President, Manufacturing
Mr. Steininger’s Expertise in Building Manufacturing Organizations is a Key Addition to the Acceleron Management Team
View HTML